Ligand profile
MOI
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: A0A075B6I6
Identifiers
Database identifiers and provenance.
- Ligand ID
MOI- PDB
1q0y- UniProt (similar protein)
P01724- Target protein
- A0A075B6I6
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 52.9
- −1 ≤ LogP ≤ 5 1.20
- MW ≤ 500 Da 285.3
- LogP ≤ 5 1.20
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 0
- TPSA ≤ 140 Ų 52.9
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[N@]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC[N@]1CC[C@]23c4c5ccc(c4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)O
InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1
BQJCRHHNABKAKU-KBQPJGBKSA-NBQJCRHHNABKAKU-KBQPJGBKSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ domain
- Source
- PDB
- Binding sites
- PF07686
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand MOI →
- PDB RCSB structure 1q0y →
- UniProt UniProt P01724 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “MOI”) →
Other ligands for this protein
Quick navigation to other ligands bound to A0A075B6I6.
PDB 54
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 29
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).